Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | 373 295 | déclaré | 05 mars 2026 | tx 42+3 281 830−1 034 026 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 05 mars 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 248 865 | 0.00 USD | |
| 05 mars 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 373 295 | 0.00 USD | deriv |
| 02 mars 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 29 282 | 14.47 USD | |
| 02 févr. 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 15 500 | 14.69 USD | |
| 15 janv. 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 197 153 | 7.57 USD | |
| 15 janv. 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 136 193 | 13.58 USD | |
| 16 janv. 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 2 847 | 7.57 USD | |
| 16 janv. 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 1 995 | 13.89 USD | |
| 15 janv. 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 197 153 | 0.00 USD | deriv |
| 16 janv. 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 2 847 | 0.00 USD | deriv |
| 06 janv. 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 7 715 | 11.09 USD | |
| 30 sept. 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 29 775 | 14.37 USD | |
| 30 sept. 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 200 | 15.01 USD | |
| 31 mars 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 21 490 | 3.46 USD | |
| 06 mars 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 180 118 | 0.00 USD | |
| 06 mars 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 270 177 | 0.00 USD | deriv |
| 03 mars 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 4 595 | 3.15 USD | |
| 05 févr. 2025 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 36 310 | 1.57 USD | |
| 05 févr. 2025 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 36 310 | 0.00 USD | deriv |
| 03 févr. 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 11 855 | 3.47 USD | |
| 06 janv. 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 7 471 | 4.04 USD | |
| 04 nov. 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 63 690 | 1.57 USD | |
| 04 nov. 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 63 690 | 0.00 USD | deriv |
| 30 sept. 2024 | SALE | Amylyx Pharmaceuticals, Inc. | 18 589 | 3.20 USD | |
| 16 avr. 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 179 850 | 0.00 USD |